In the News

Keep up to date with the latest news articles from around the world.

Articles represent the views of their authors and not ME/CFS SA. Always seek advice from a registered health practitioner before changing your care plan.

21 February, 2024

MedUni Vienna Scientists Identify Possible Biomarkers For Chronic Fatigue Syndrome

Up to 80,000 people in Austria are estimated to suffer from chronic fatigue syndrome, also known as ME/CFS or myalgic encephalomyelitis/chronic fatigue syndrome. The number of ME/CFS patients is expected to rise drastically due to long-term effects of the COVID-19 pandemic. However, research in the field has neither identified mechanisms of disease onset nor causal treatment approaches. Scientists at MedUni Vienna have now identified possible biomarkers that could improve the diagnosis and treatment of long-lasting and debilitating fatigue. The study has recently been published in the Journal of Clinical Medicine.

20 February, 2024

Study: COVID-19 Associated With Quadrupled Risk Of Chronic Fatigue

COVID-19 is associated with quadruple the risk of developing chronic fatigue, according to researchers at the Centers for Disease Control and Prevention and University of Washington.

20 February, 2024

UT Researchers Contribute To Knowledge On Long COVID

University of Texas researchers recently analyzed the symptoms of long COVID and discovered a blood marker that differs in patients with fibromyalgia in comparison to long COVID, helping researchers contrast the two conditions.

19 February, 2024

Tonix Signs On Rho To Support NDA Submission For Fibromyalgia Drug

Tonix Pharmaceuticals has tapped CRO Rho to support the New Jersey-based biotech’s plans to submit a new drug application (NDA) for its drug designed to manage fibromyalgia. The deal follows the December release of phase 3 study results assessing Tonmya, a sublingual tablet formulation of cyclobenzaprine hydrochloride. In the study, the drug reduced daily pain compared to placebo in participants with fibromyalgia, a result that was statistically significant.

19 February, 2024

Urgent Call For Action: Severe ME Patients In The UK Suffer From Neglect And Mistreatment

Severe ME patients in the UK face accusations of neglect and mistreatment by the National Health Service, despite recent improvements in guidelines. Organizations call for specific protocols to address this crisis, as one-quarter of patients are severely afflicted and bedridden.

18 February, 2024

How Much More Must People With Severe ME Tolerate From The UK’s NHS?

In recent months, multiple cases of people living with severe myalgic encephalomyelitis (ME, also referred to as chronic fatigue syndrome, CFS) being neglected and mistreated by the UK’s NHS have come to light. This is despite improvements in official guidelines – and historical outcry over medical professionals’ treatment of people living with the disease. So, one organisation is demanding the government acts – and you can get involved too. However, it may take more than this to change the health service’s institutionalised failures around ME.

18 February, 2024

Risk For Chronic Fatigue Soars Among Those Who Had COVID-19, Study Says

People who have had COVID-19 have a significantly higher risk of suffering chronic fatigue than those who haven’t had the disease, a new study published Wednesday shows. “Our data indicate that COVID-19 is associated with a significant increase in new fatigue diagnoses,” according to the study, published by the Centers for Disease Control and Prevention in the journal Emerging Infectious Diseases.

17 February, 2024

Estimates Of Incidence And Predictors Of Fatiguing Illness After SARS-CoV-2 Infection

This study aimed to estimate the incidence rates of post–COVID-19 fatigue and chronic fatigue and to quantify the additional incident fatigue caused by COVID-19. We analyzed electronic health records data of 4,589 patients with confirmed COVID-19 during February 2020–February 2021 who were followed for a median of 11.4 (interquartile range 7.8–15.5) months and compared them to data from 9,022 propensity score–matched non–COVID-19 controls. Among COVID-19 patients (15% hospitalized for acute COVID-19), the incidence rate of fatigue was 10.2/100 person-years and the rate of chronic fatigue was 1.8/100 person-years. Compared with non–COVID-19 controls, the hazard ratios were 1.68 (95% CI 1.48–1.92) for fatigue and 4.32 (95% CI 2.90–6.43) for chronic fatigue. The observed association between COVID-19 and the significant increase in the incidence of fatigue and chronic fatigue reinforces the need for public health actions to prevent SARS-CoV-2 infections.

17 February, 2024

Long-COVID's Lingering Shadow: Autonomic Dysfunction In Over Half Of Patients

Recent findings indicate that more than half of long-COVID patients suffer from autonomic dysfunction, a condition affecting essential bodily functions. Risk factors include gender and chronic heart disease, while the molecule FGF21 may hold the key to future treatments.

16 February, 2024

Long Covid Linked To Chronic Pain Conditions

People with chronic pain conditions such as fibromyalgia, chronic fatigue, migraine and irritable bowel syndrome are significantly more likely to have symptoms of Long Covid after a COVID-19 infection, according to a large new analysis.

Sort By

Search Articles